188 related articles for article (PubMed ID: 20146105)
1. Prognostic significance of telomerase activity and some tumor markers in non-small cell lung cancer.
Hashim M; Sayed M; Samy N; Elshazly S
Med Oncol; 2011 Mar; 28(1):322-30. PubMed ID: 20146105
[TBL] [Abstract][Full Text] [Related]
2. [Telomerase activity in human non-small cell lung cancer (NSCLC)].
Liu H; Zhang W; Cai C; Xu J; Xu Y
Zhonghua Bing Li Xue Za Zhi; 2000 Apr; 29(2):89-91. PubMed ID: 11866896
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer.
Han H; Landreneau RJ; Santucci TS; Tung MY; Macherey RS; Shackney SE; Sturgis CD; Raab SS; Silverman JF
Hum Pathol; 2002 Jan; 33(1):105-10. PubMed ID: 11823980
[TBL] [Abstract][Full Text] [Related]
4. Expression of high mobility group box - B1 (HMGB-1) and matrix metalloproteinase-9 (MMP-9) in non-small cell lung cancer (NSCLC).
Wang JL; Wu DW; Cheng ZZ; Han WZ; Xu SW; Sun NN
Asian Pac J Cancer Prev; 2014; 15(12):4865-9. PubMed ID: 24998555
[TBL] [Abstract][Full Text] [Related]
5. CHID1 Is a Novel Prognostic Marker of Non-Small Cell Lung Cancer.
Kovaleva OV; Rashidova MA; Samoilova DV; Podlesnaya PA; Tabiev RM; Mochalnikova VV; Gratchev A
Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466316
[TBL] [Abstract][Full Text] [Related]
6. Carcinoembryonic antigen (CEA) as tumor marker in lung cancer.
Grunnet M; Sorensen JB
Lung Cancer; 2012 May; 76(2):138-43. PubMed ID: 22153832
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of circulating c-met messenger RNA is significantly correlated with nodal stage and early recurrence in non-small cell lung cancer.
Cheng TL; Chang MY; Huang SY; Sheu CC; Kao EL; Cheng YJ; Chong IW
Chest; 2005 Sep; 128(3):1453-60. PubMed ID: 16162743
[TBL] [Abstract][Full Text] [Related]
8. Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer.
Zhang D; Jin X; Wang F; Wang S; Deng C; Gao Z; Guo C
Ann Surg Oncol; 2007 Dec; 14(12):3581-92. PubMed ID: 17899287
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC).
Liu YZ; Jiang YY; Hao JJ; Lu SS; Zhang TT; Shang L; Cao J; Song X; Wang BS; Cai Y; Zhan QM; Wang MR
Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526
[TBL] [Abstract][Full Text] [Related]
10. Prognostic stratification of stage IIIA pN2 non-small cell lung cancer by hierarchical clustering analysis of tissue microarray immunostaining data: an Alpe Adria Thoracic Oncology Multidisciplinary Group study (ATOM 014).
Grossi F; Spizzo R; Bordo D; Cacitti V; Valent F; Rossetto C; Follador A; Di Terlizzi S; Aita M; Morelli A; Fasola G; Consiglieri C; Ceschia T; Beltrami CA; Belvedere O
J Thorac Oncol; 2010 Sep; 5(9):1354-60. PubMed ID: 20631638
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of telomerase activity in non-small cell lung cancers.
Taga S; Osaki T; Ohgami A; Imoto H; Yasumoto K
Ann Surg; 1999 Nov; 230(5):715-20. PubMed ID: 10561097
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
Wang D; Hao T; Pan Y; Qian X; Zhou D
Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
[TBL] [Abstract][Full Text] [Related]
13. Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer.
Marchetti A; Bertacca G; Buttitta F; Chella A; Quattrocolo G; Angeletti CA; Bevilacqua G
Clin Cancer Res; 1999 Aug; 5(8):2077-81. PubMed ID: 10473089
[TBL] [Abstract][Full Text] [Related]
14. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
Le H; Zeng F; Xu L; Liu X; Huang Y
Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
[TBL] [Abstract][Full Text] [Related]
15. High levels of Phosphatase and Tensin Homolog Expression Predict Favorable Prognosis in Patients with Non-small Cell Lung Cancer.
Li X; Yang Y; Zhang H; Yue W; Zhang T; Lu B; Li J; Liu Z; Wang Q; Gao Y; Hu A; Zhang H; Shi H; Hu F; Li B
Cell Biochem Biophys; 2015 Dec; 73(3):631-7. PubMed ID: 27259304
[TBL] [Abstract][Full Text] [Related]
16. High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic stage.
Albanell J; Lonardo F; Rusch V; Engelhardt M; Langenfeld J; Han W; Klimstra D; Venkatraman E; Moore MA; Dmitrovsky E
J Natl Cancer Inst; 1997 Nov; 89(21):1609-15. PubMed ID: 9362159
[TBL] [Abstract][Full Text] [Related]
17. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
Metzger R; Vallbohmer D; Müller-Tidow C; Higashi H; Bollschweiler E; Warnecke-Eberz U; Brabender J; Baldus SE; Xi H; Berdel WE; Serve H; Hoelscher AH; Schneider PM
Anticancer Res; 2009 Apr; 29(4):1157-62. PubMed ID: 19414359
[TBL] [Abstract][Full Text] [Related]
18. Study of telomerase activity in pleural lavage fluid specimens in patients with non-small-cell lung cancer and its clinical significance.
Li W; Ni Y; Tu Z; Wu S; Wu Z; Zheng S
Eur J Cardiothorac Surg; 2009 Sep; 36(3):460-4. PubMed ID: 19502078
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.
Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G
Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148
[TBL] [Abstract][Full Text] [Related]
20. [Association of HAb18G with clinicopathologic features and prognosis in non-small cell carcinoma of lung].
Xu XY; Zhi C; Li YM; Qi WJ; Mei JJ; Yan ZM; Shen H
Zhonghua Bing Li Xue Za Zhi; 2012 Mar; 41(3):151-5. PubMed ID: 22800476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
